Remedy Meds has acquired Thirty Madison for $500 million, aiming to create one of the largest consumer-focused virtual healthcare platforms in women's health.

Information on the Target

The acquisition of Thirty Madison by Remedy Meds for $500 million marks a pivotal development in the landscape of direct-to-consumer digital health, particularly within women’s health. Remedy Meds, founded in 2024, has quickly established itself in the telehealth space focusing on weight management therapies complemented by a vertically integrated pharmacy model. As a result, the company has projected revenues exceeding $450 million for 2025 and is on the path to profitability.

Thirty Madison, which has been operational since 2017, features a diverse portfolio of consumer health brands including Nurx, which focuses on women's health and reproductive care, Keeps for men's hair loss, and Cove specializing in migraine treatments. This acquisition allows Remedy Meds to leverage Thirty Madison's recognized brand equity, clinical infrastructure, and existing patient relationships, effectively positioning it as a leader in consumer-focused virtual healthcare within the U.S.

Industry Overview in the Target’s Specific Country

The U.S. digital health market has been experiencing rapid growth and transformation, particularly in segments dedicated to women's health. This evolution has been accelerated by increasing consumer preferences for m